Dr. Elizabeth A. Kendrick, MD

Dr. Kendrick practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Kendrick's NPI, 1972522860, was assigned on July 19, 2006. Dr. Kendrick graduated from Keck School of Medicine of USC in 1985. Dr. Kendrick holds California license G58777.

Dr. Kendrick's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Kendrick's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Kendrick is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Kendrick to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kendrick practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kendrick's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Kendrick's licenses on file in 5 states: California, Maine, Oregon, Washington and Idaho.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Kendrick treats.

CMS data shows 896 Medicare services from Dr. Kendrick across 6 procedure codes in 2024, for 295 Medicare patients. Medicare paid $78,661 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 295 Medicare patients who saw Dr. Kendrick in 2024. The largest group is under 65, with 171 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 61% are also on Medicaid. Their average risk score is 6.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kendrick's median patient age at 55, with 41% women.

In 2024, Dr. Kendrick wrote 760 Medicare Part D claims for 181 patients. 86% of them were for generic drugs. CMS names the drug for 517 of them, across 18 drugs with 11 or more claims each, at $31,805 in total drug cost. In 2023, CMS named 626 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kendrick for performance year 2024, reported as part of a group. Dr. Kendrick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kendrick as offering telehealth.

Dmand AI links 1 paper to Dr. Kendrick.

CMS Open Payments shows 5 general payments to Dr. Kendrick from 3 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $174.

Dr. Kendrick graduated from Keck School of Medicine of USC in 1985. Dr. Kendrick is a member of ASN.

Dr. Kendrick is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.